ABC294640 in Treating Patients With Advanced Solid Tumors (ABC-101)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01488513
Recruitment Status : Completed
First Posted : December 8, 2011
Last Update Posted : August 20, 2015
Apogee Biotechnology Corporation
Medical University of South Carolina
FDA Office of Orphan Products Development
National Cancer Institute (NCI)
Information provided by (Responsible Party):
RedHill Biopharma Limited

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2014
  Actual Study Completion Date : July 2015